BB Biotech AG (BBAGF)
64.36
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
BB Biotech EPS Diluted (Quarterly) : 10.35 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.35 |
| March 31, 2026 | -0.4946 |
| December 31, 2025 | 10.70 |
| September 30, 2025 | 10.20 |
| June 30, 2025 | -2.219 |
| March 31, 2025 | -4.896 |
| December 31, 2024 | 1.242 |
| September 30, 2024 | -3.308 |
| June 30, 2024 | -1.756 |
| March 31, 2024 | 5.432 |
| December 31, 2023 | 2.241 |
| September 30, 2023 | -0.9982 |
| June 30, 2023 | -0.2733 |
| March 31, 2023 | -5.003 |
| December 31, 2022 | -0.6648 |
| September 30, 2022 | 3.962 |
| June 30, 2022 | -4.388 |
| March 31, 2022 | -5.878 |
| December 31, 2021 | -10.71 |
| September 30, 2021 | -4.101 |
| June 30, 2021 | 2.546 |
| March 31, 2021 | 4.404 |
| December 31, 2020 | 13.28 |
| September 30, 2020 | -7.752 |
| June 30, 2020 | 22.10 |
| Date | Value |
|---|---|
| March 31, 2020 | -14.13 |
| December 31, 2019 | 9.213 |
| September 30, 2019 | -6.989 |
| June 30, 2019 | -6.046 |
| March 31, 2019 | 16.11 |
| December 31, 2018 | -11.65 |
| September 30, 2018 | 4.439 |
| June 30, 2018 | -1.807 |
| March 31, 2018 | 0.5379 |
| December 31, 2017 | -2.848 |
| September 30, 2017 | 6.846 |
| June 30, 2017 | 1.899 |
| March 31, 2017 | 6.747 |
| December 31, 2016 | -0.4395 |
| September 30, 2016 | 7.288 |
| June 30, 2016 | 0.6597 |
| March 31, 2016 | -21.90 |
| December 31, 2015 | 9.238 |
| September 30, 2015 | -10.74 |
| June 30, 2015 | 6.373 |
| March 31, 2015 | 7.082 |
| December 31, 2014 | 13.31 |
| September 30, 2014 | 9.333 |
| June 30, 2014 | 3.876 |
| March 31, 2014 | 1.292 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| UBS Group AG | 0.8742 |
| GAM Holding AG | -- |
| Julius Bär Gruppe AG | -- |
| Partners Group Holding AG | -- |
| Vontobel Holding AG | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 570.82M |
| Revenue (Quarterly) | 139.22M |
| Total Expenses (Quarterly) | -431.60M |
| Enterprise Value | -264.21M |
| Earnings Yield | 47.79% |
| Operating Earnings Yield | 47.81% |
| Normalized Earnings Yield | 47.79 |